Concepedia

Yanqiao Zhang

YZ

Statistics

Publications

6

Citations

202

H-Index

6

Active since

2020

Affiliations

Third Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Peking University

Peking University Cancer Hospital

Sun Yat-sen University

Yanqiao Zhang is an author at Third Affiliated Hospital of Harbin Medical University specializing in oncology, medicine, and pharmacology.

Publications per year

2020–2024

6

Publications

6

Efficacy, Safety, and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial

Ming Lu, Panpan Zhang, Yanqiao Zhang et al. · Clinical Cancer Research · 2020 · 113 citations

, , +17

First-in-human dose escalation and expansion study of SYSA1801, an antibody-drug conjugate targeting claudin 18.2 in patients with resistant/refractory solid tumors.

Yakun Wang, Jifang Gong, Rongbo Lin et al. · Journal of Clinical Oncology · 2023 · 32 citations

, , +17

Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial

Panpan Zhang, Si Shi, Jianming Xu et al. · European Journal of Cancer · 2024 · 21 citations · Full text

, , +17

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study

Jian Li, Xinhua Zhang, Yanhong Deng et al. · The Oncologist · 2022 · 13 citations · Full text

, , +14

Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China

Jian Li, Jun Zhang, Yanqiao Zhang et al. · European Journal of Cancer · 2023 · 12 citations

, , +7

1–5 of 6